top of page
pexels-brongkie-brongkie-1110675817-20881525_edited.jpg

Are GLP-1S the Miracle Drug?

Updated: May 3

Episode Recap:

In this episode, Dr. Drew Crawford explores the growing popularity of GLP-1s for weight loss and diabetes management. He discusses the significant weight loss observed in many users, alongside potential side effects such and the need for ongoing medication to maintain results. The episode also addresses concerns about accessibility, including medication shortages and high costs, and emphasizes the importance of medical supervision when considering these treatments.

Show Notes:

  • 1:07 - What are GLP-1s and What Do They Do?

  • 7:07 - The Benefits of GLP-1s

  • 8:01 - The Adverse Effects of GLP-1s

  • 11:10 - Common Reasons Why Patients Should Not Take These Medications

  • 12:53 - Who Should Be Monitored?

  • 16:24 - Liraglutide versus Semaglutide

    • 18:09 - Study #1

    • 20:13 - Study #2

    • 22:54 - Study #3

  • 23:32 - Should GLP-1s Be A Long-Term Treatment?


Resources & Articles Mentioned:



About Your Host:

Dr. Drew Crawford is a board-certified gastroenterologist with an active practice in Tulsa, Oklahoma. He also serves as the Program Director for the Gastroenterology Fellowship at Oklahoma State University. Additionally, and more relevant to this podcast, Dr. Drew Crawford is board-certified in obesity medicine. In the BMI Podcast, we will go Beyond Measurements & Image to build healthier lifestyles, elevate your well-being, and transform lives!


The BMI Podcast Resources:


The BMI Podcast Disclaimer:

The BMI Podcast is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

 
 
 

Related Posts

Moving is N.E.A.T.!

About This Episode: In this episode, Dr. Drew Crawford explains  the the 4 components of metabolism, focusing specifically on...

 
 
 
How Do You Sleep At Night?

Episode Recap: In this episode, Dr. Drew Crawford discusses the role sleep has on our weight, specifically focuses on the circadian...

 
 
 

Komentarze


bottom of page